S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Pharmacist Enjay T. Griggs Named Pinnacle Lifetime Member

With over 26 years of experience in community pharmacy, Enjay T. Griggs, BPharm, has been inducted as a Pinnacle Lifetime Member by The Inner Circle. Her career, rooted in the Pittsburgh region, is defined by a focus on medication safety, patient education, and the administration of critical immunization programs.

Pharmacist Enjay T. Griggs Named Pinnacle Lifetime Member
Photo: Bio & News

A graduate of the Duquesne University School of Pharmacy, Griggs has built a diverse resume spanning independent pharmacies, CVS Caremark, and Rite Aid. Her clinical expertise covers medication therapy management, drug utilization review, and complex immunization services. During her tenure as a Floater Pharmacist at Rite Aid, she supported operations across 26 different locations, balancing high-volume service demands with rigorous patient safety standards.

Griggs is particularly noted for her ability to navigate insurance hurdles for patients, ensuring access to essential treatments. Her professional track record includes supervising pharmacy technicians and interns while managing inventory and compliance protocols. She credits her success to the mentorship of Dr. John Martin and Dr. Iona Black, alongside the support of her family. As the healthcare landscape shifts, she continues to prioritize a patient-centered philosophy that emphasizes direct engagement and clear communication to improve overall health outcomes.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!